Our track-record is not only based on our experience as deal makers and negotiators, but equally reflect the domain knowledge and practical industry experience that the partners and senior advisors at CATALYSIS bring to each assignment.
Our expertise is focused on established as well as rapidly changing industry segments, including Diagnostics, Medical Devices, Medical Imaging, Biotechnology and Drug Delivery.
Together with our Senior Advisors we are able to bring a global, current industry perspective to each assignment and then tailor our advice to the individual client’s needs providing an in-depth understanding of the competitive landscape and access to the relevant network of industry and investor contacts. The outcome is a client-focused process carefully crafted to deliver tactical and strategic guidance throughout each transaction process.
CATALYSIS CAPITAL PARTNERS LTD. ceased regulated activities as of November 1, 2017.
Move the cursor on to the transaction tombstones below to view a synopsis of the transaction and CATALYSIS’ involvement.
1) Consulting services performed prior to the formation of CATALYSIS CAPITAL PARTNERS LTD. and authorisation and regulation by FCA UK.
2) Transactions completed while CATALYSIS CAPITAL PARTNERS LTD. was authorized and regulated by the Financial Conduct Authority (FCA) UK.